Literature DB >> 19089740

Rare (new) entities of the breast and medullary carcinoma.

Maria P Foschini1, Vincenzo Eusebi.   

Abstract

Rare tumours are a heterogeneous group of conditions that encompass benign to malignant lesions both of stromal and epithelial origin. Here some of these tumours are described, in which the authors have most familiarity. An outline of medullary carcinoma is also presented.

Entities:  

Mesh：

Year:  2009        PMID： 19089740     DOI： 10.1080/00313020802563528

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


  13 in total

1.  Basal cell adenoma of the breast.

Authors:  Michael Van Vrancken; Mariam Mir; William Herlihy
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-10

2.  Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.

Authors:  J Huober; S Gelber; A Goldhirsch; A S Coates; G Viale; C Öhlschlegel; K N Price; R D Gelber; M M Regan; B Thürlimann
Journal:  Ann Oncol       Date:  2012-06-14       Impact factor: 32.976

3.  Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland.

Authors:  Salvatore Piscuoglio; Nicola Fusco; Charlotte K Y Ng; Luciano G Martelotto; Arnaud da Cruz Paula; Nora Katabi; Brian P Rubin; Alena Skálová; Ilan Weinreb; Britta Weigelt; Jorge S Reis-Filho
Journal:  Histopathology       Date:  2016-01-04       Impact factor: 5.087

4.  Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.

Authors:  Nicola Fusco; Pierre-Emmanuel Colombo; Luciano G Martelotto; Maria R De Filippo; Salvatore Piscuoglio; Charlotte K Y Ng; Raymond S Lim; William Jacot; Anne Vincent-Salomon; Jorge S Reis-Filho; Britta Weigelt
Journal:  Histopathology       Date:  2015-06-29       Impact factor: 5.087

5.  Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.

Authors:  A-Yong Cao; Min He; Liang Huang; Zhi-Ming Shao; Gen-Hong Di
Journal:  World J Surg Oncol       Date:  2013-04-22       Impact factor: 2.754

6.  Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands.

Authors:  Ilan Weinreb; Salvatore Piscuoglio; Luciano G Martelotto; Daryl Waggott; Charlotte K Y Ng; Bayardo Perez-Ordonez; Nicholas J Harding; Javier Alfaro; Kenneth C Chu; Agnes Viale; Nicola Fusco; Arnaud da Cruz Paula; Caterina Marchio; Rita A Sakr; Raymond Lim; Lester D R Thompson; Simion I Chiosea; Raja R Seethala; Alena Skalova; Edward B Stelow; Isabel Fonseca; Adel Assaad; Christine How; Jianxin Wang; Richard de Borja; Michelle Chan-Seng-Yue; Christopher J Howlett; Anthony C Nichols; Y Hannah Wen; Nora Katabi; Nicholas Buchner; Laura Mullen; Thomas Kislinger; Bradly G Wouters; Fei-Fei Liu; Larry Norton; John D McPherson; Brian P Rubin; Blaise A Clarke; Britta Weigelt; Paul C Boutros; Jorge S Reis-Filho
Journal:  Nat Genet       Date:  2014-09-21       Impact factor: 38.330

Review 7.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

8.  Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma.

Authors:  Inhye Park; Jiyoung Kim; Minkuk Kim; Soo Youn Bae; Se Kyung Lee; Won Ho Kil; Jeong Eon Lee; Seok Jin Nam
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

9.  Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases.

Authors:  Zhaohui Chu; Hao Lin; Xiaohua Liang; Ruofan Huang; Qiong Zhan; Jingwei Jiang; Xinli Zhou
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

10.  Prognostic Role of Adjuvant Chemotherapy in Node-Negative (N0), Triple-Negative (TN), Medullary Breast Cancer (MBC) in the Korean Population.

Authors:  SeungTaek Lim; Se Ho Park; Heong Kyu Park; Min Hee Hur; Se Jeong Oh; Young Jin Suh
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.